Upload
brittney-king
View
217
Download
0
Tags:
Embed Size (px)
Citation preview
The Palliation of The Palliation of Dyspnea in Dyspnea in
Far Advanced Far Advanced Lung CancerLung Cancer
Dr. Anna TowersDr. Anna Towers
Division of Palliative CareDivision of Palliative Care
McGill UniversityMcGill University
Palliation of dyspneaPalliation of dyspnea
Work of:Work of:
Dr. Sam Ahmedzai Dr. Sam Ahmedzai
Professor of Palliative MedicineProfessor of Palliative Medicine
Sheffield, UKSheffield, UK
Effect of palliative drugs on Effect of palliative drugs on respiratory muscles and respiratory muscles and
ventilatory activityventilatory activity
The benzodiazepine midazolam reduces The benzodiazepine midazolam reduces tidal volume and depresses ventilation by tidal volume and depresses ventilation by affecting the thoracoabdominal musclesaffecting the thoracoabdominal muscles
Opioids inhibit rib cage movementOpioids inhibit rib cage movement
Effect of opioids on the Effect of opioids on the medullary respiratory medullary respiratory
centrecentre
Opioids reduce the hypercapnic drive in the Opioids reduce the hypercapnic drive in the medullary centre (respiratory depression) medullary centre (respiratory depression)
(the hypercapnic drive = mathematical (the hypercapnic drive = mathematical relationship between ventilation and relationship between ventilation and ppCO2)CO2)
i.e. opioids render the the medullary centre less i.e. opioids render the the medullary centre less sensitive to rising sensitive to rising ppCO2 levelsCO2 levels
Effect of severe Effect of severe hypercapnea on dyspneahypercapnea on dyspnea Dyspnea may abate when the CO2 level Dyspnea may abate when the CO2 level
rises above 75 – this could be due to the rises above 75 – this could be due to the compensatory release of natural compensatory release of natural endorphinsendorphins
Patients with severe hypercapnea are Patients with severe hypercapnea are often somnolent (CO2 narcosis), partially often somnolent (CO2 narcosis), partially due to the above mechanismdue to the above mechanism
Clinical definition Clinical definition of dyspnea of dyspnea
Greek : Dys= bad or difficult Greek : Dys= bad or difficult
Pneo= breathingPneo= breathing
A A SUBJECTIVESUBJECTIVE sensation of difficulty in sensation of difficulty in breathing, not necessarily related to breathing, not necessarily related to exertion, that compels the individual to exertion, that compels the individual to increase his ventilation or decrease his increase his ventilation or decrease his activity activity (Ahmedzai)(Ahmedzai)
Effects of dyspnea Effects of dyspnea on the patienton the patient
Reduction in :Reduction in :quality of life, general function, activities of quality of life, general function, activities of daily livingdaily living
Although dyspnea is subjective, the Although dyspnea is subjective, the effects on function are objectively effects on function are objectively observableobservable
Terms often confused Terms often confused with dyspneawith dyspnea
Tachypnea (e.g. increased breathing rate Tachypnea (e.g. increased breathing rate caused by fever)caused by fever)
Hyperpnea (increased ventilation through Hyperpnea (increased ventilation through metabiolic acidosis e.g. diabetic metabiolic acidosis e.g. diabetic ketoacidosis)ketoacidosis)
Hyperventilation (Psychologically induced Hyperventilation (Psychologically induced increased respiration) increased respiration)
Patients’ description Patients’ description of dyspneaof dyspnea
““I feel like I am suffocating.”I feel like I am suffocating.” ““I am afraid and feel like I am drowning.”I am afraid and feel like I am drowning.” ““I have a tightness in the chest”I have a tightness in the chest”
Prevalence of dyspnea in Prevalence of dyspnea in terminal illnessterminal illness
70% of those in the last 6 weeks of life – 70% of those in the last 6 weeks of life – all diagnoses all diagnoses (National Hospice Study U.S.A.)(National Hospice Study U.S.A.)
60% of those with lung cancer 60% of those with lung cancer (St. Christopher’s Hospice, UK)(St. Christopher’s Hospice, UK)
Causes of dyspnea Causes of dyspnea in lung cancerin lung cancer
PulmonaryPulmonary PleuralPleural Thoracic cageThoracic cage Cardiac/ pericardialCardiac/ pericardial
Pulmonary causes of Pulmonary causes of dyspnea dyspnea
in lung cancerin lung cancer Airway collapse/ lung collapseAirway collapse/ lung collapse ThromboembolismThromboembolism PneumoniaPneumonia Lymphangitis carcinomatosaLymphangitis carcinomatosa Radiation fibrosisRadiation fibrosis Noncancer causes: COPD/asthmaNoncancer causes: COPD/asthma
Pleural causesPleural causes
Pleural effusionPleural effusion Pleural tumourPleural tumour
Impaired thoracic cage Impaired thoracic cage functionfunction
Respiratory muscle wasting in Respiratory muscle wasting in anorexia/cachexia syndrome, leading to anorexia/cachexia syndrome, leading to respiratory muscle fatiguerespiratory muscle fatigue
Chest wall tumoursChest wall tumours
Pericardial causes Pericardial causes
Pericardial tumour, effusion, tamponadePericardial tumour, effusion, tamponade
Management of dyspneaManagement of dyspnea
DIAGNOSE AND TREAT DIAGNOSE AND TREAT REVERSIBLE CAUSES REVERSIBLE CAUSES
Common reversible Common reversible causescauses
Pleural effusionPleural effusion PneumoniaPneumonia Tumour mass or lymphangitis that can be Tumour mass or lymphangitis that can be
reduced with palliative oncologial reduced with palliative oncologial treatmentstreatments
Superior vena cava syndromeSuperior vena cava syndrome
SVC syndromeSVC syndrome
Superior vena cava syndrome is Superior vena cava syndrome is considered an oncological and palliative considered an oncological and palliative EMERGENCYEMERGENCY
Is usually very responsive to radiotherapy Is usually very responsive to radiotherapy and high-dose corticosteroidsand high-dose corticosteroids
Treatment should always be considered Treatment should always be considered unless prognosis is very short unless prognosis is very short
Treatment of carcinomatous Treatment of carcinomatous lymphangitislymphangitis
Palliative chemotherapyPalliative chemotherapy RadiotherapyRadiotherapy Where prognosis is very short: Where prognosis is very short:
High dose dexamethasone High dose dexamethasone
(Start with at least 12 mg per day and (Start with at least 12 mg per day and titrate down. Stop steroid if there is titrate down. Stop steroid if there is no no response after a 2-week trial.)response after a 2-week trial.)
General drug treatment General drug treatment for dyspneafor dyspnea
Inhaled or nebulized bronchodilatorsInhaled or nebulized bronchodilators Corticosteroids (usually at least 12 mg Corticosteroids (usually at least 12 mg
per day of dexamethasone is required)per day of dexamethasone is required) Respiratory sedatives (opioids, Respiratory sedatives (opioids,
nonopioids)nonopioids)
Respiratory sedativesRespiratory sedatives
Opioids (morphine, hydromorphone, Opioids (morphine, hydromorphone, fentanyl, oxycodone, methadone etc)fentanyl, oxycodone, methadone etc)
BenzodiazepinesBenzodiazepines
Palliative approachPalliative approach
Aim is to prolong (good quality) life, or to Aim is to prolong (good quality) life, or to improve quality of life where life cannot improve quality of life where life cannot be prolongedbe prolonged
Discuss treatable causes with patient Discuss treatable causes with patient and/or family and obtain consent to treatand/or family and obtain consent to treat
Consider the prognosis, adverse effects, Consider the prognosis, adverse effects, social considerations (such as the burden social considerations (such as the burden of travel from home etc)of travel from home etc)
Palliative oncological Palliative oncological treatments for dyspneatreatments for dyspnea
Aim for improved quality of life rather Aim for improved quality of life rather than life prolongationthan life prolongation
Palliative chemotherapyPalliative chemotherapy RadiotherapyRadiotherapy
external beam or brachytherapyexternal beam or brachytherapy Endobronchial laser therapyEndobronchial laser therapy Endobronchial stentEndobronchial stent
Respiratory sedativesRespiratory sedatives
Have the effect of suppressing respiratory Have the effect of suppressing respiratory awareness – with or without an effect on awareness – with or without an effect on ventilatory driveventilatory drive
Non-opioidsNon-opioids OpioidsOpioids
Respiratory sedatives: Respiratory sedatives: non-opioidnon-opioid
Benzodiazepines:Benzodiazepines: Lorazepam (Ativan) , midazolam)Lorazepam (Ativan) , midazolam)
Phenothiazines:Phenothiazines: (methotrimeprazine (Nozinan)(methotrimeprazine (Nozinan)
Respiratory sedatives: Respiratory sedatives: opioidopioid
Reduce anxietyReduce anxiety Reduce sensitivity to hypercapneaReduce sensitivity to hypercapnea Improve cardiac functionImprove cardiac function Reduce concurrent pain that may be a Reduce concurrent pain that may be a
factor in producing anxiety and sensation factor in producing anxiety and sensation of dyspneaof dyspnea
Respiratory sedatives: Respiratory sedatives: opioidopioid
Note: codeine does NOT reduce Note: codeine does NOT reduce breathlessnessbreathlessness
Most commonly used opioids to control Most commonly used opioids to control dyspnea:dyspnea: morphinemorphine hydromorphone (Dilaudid)hydromorphone (Dilaudid) Fentanyl patchFentanyl patch oxycodoneoxycodone
Nebulized opioidsNebulized opioids
Route of delivery being studiedRoute of delivery being studied Note: nebulized morphine may induce Note: nebulized morphine may induce
histamine release and bronchospasm in histamine release and bronchospasm in some patientssome patients
How to use opioids in How to use opioids in dyspnea managementdyspnea management
Use prn only if dyspnea is intermittent Use prn only if dyspnea is intermittent (aggravated by exertion, anxiety)(aggravated by exertion, anxiety)
Have patient control the prn medicationHave patient control the prn medication Give just enough to relieve dyspnea, Give just enough to relieve dyspnea,
aiming, if possible, to avoid sedationaiming, if possible, to avoid sedation If combined with a benzodiazepine, small If combined with a benzodiazepine, small
doses of opioid are usually sufficientdoses of opioid are usually sufficient